Provided by Tiger Fintech (Singapore) Pte. Ltd.

Monopar Therapeutics

37.58
-0.0200-0.05%
Post-market: 37.580.00000.00%18:31 EDT
Volume:15.75K
Turnover:587.37K
Market Cap:229.18M
PE:-19.13
High:38.49
Open:36.37
Low:35.63
Close:37.60
Loading ...

BRIEF-Monopar Therapeutics Announces Proposed Public Offering

Reuters
·
29 Oct 2024

BUZZ-Microcap Monopar Therapeutics tumbles on planned stock offering

Reuters
·
29 Oct 2024

Monopar Therapeutics announces common stock offering, no amount given

TIPRANKS
·
29 Oct 2024

Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
29 Oct 2024

Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock

GlobeNewswire
·
29 Oct 2024

Monopar Therapeutics Shares Down 1.7%; AstraZeneca Reports 9.9% Stake in Co

THOMSON REUTERS
·
28 Oct 2024

Monopar Therapeutics Shares Down 17.3% Premarket; AstraZeneca Reports 9.9% Stake in Co

THOMSON REUTERS
·
28 Oct 2024

BRIEF-Astrazeneca Reports 9.9% Passive Stake In Monopar Therapeutics As Of Oct 23 - SEC Filing

Reuters
·
28 Oct 2024

AstraZeneca Reports 9.9% Passive Stake in Monopar Therapeutics as of Oct 23 - SEC Filing

THOMSON REUTERS
·
28 Oct 2024

Individual investors are Monopar Therapeutics Inc.'s (NASDAQ:MNPR) biggest owners and were rewarded after market cap rose by US$40m last week

Simply Wall St.
·
26 Oct 2024

Monopar Therapeutics Secures License for Wilson Disease Treatment

TipRanks
·
25 Oct 2024

Monopar Therapeutics Shares Extend Gains; Last up More Than Double at $10.99

THOMSON REUTERS
·
24 Oct 2024

Monopar Therapeutics Shares up 5.2% on Drug Licensing Deal With AstraZeneca

THOMSON REUTERS
·
24 Oct 2024

Monopar Shares Rise on AstraZeneca Licensing Deal

Dow Jones
·
24 Oct 2024

BUZZ-Monopar rises on drug licensing deal with AstraZeneca

Reuters
·
24 Oct 2024

Monopar Therapeutics enters agreement with Alexion, AstraZeneca Rare Disease

TIPRANKS
·
24 Oct 2024